Bristol Myers Reveals Death in MS CAR-T Trial, Responds to Safety Signal in Lupus Trial

A patient died in a Bristol Myers Squibb study of autoimmune CAR-T, the same technology that was called into question this summer when the two…

Sign up to read this article for free.

Get free access to a limited number of articles and choose newsletters to go straight to your inbox.